Literature DB >> 1850049

Expression of herpes simplex virus type 2 latency-associated transcript in neurons and nonneurons.

R B Tenser1, W A Edris, K A Hay, B E de Galan.   

Abstract

The presence of herpes simplex virus type 2 (HSV-2) transcription during in vivo latent infection was investigated by in situ hybridization. Latent infection of mouse dorsal root ganglion was investigated with the BamHI p fragment of HSV-2, which resulted in evidence of ganglion hybridization, and other fragments representing approximately 40% of the genome, which did not result in hybridization. Strand specificity of hybridization was investigated in studies with synthetic oligonucleotides, which supported the conclusion that a latency-associated transcript(s) had been detected. Hybridization was detected with oligonucleotides complementary to the infected-cell polypeptide 0 (ICP0) template strand but not with oligonucleotides synthesized from the ICP0 template strand. Although most hybridization occurred over neurons, in some instances hybridization appeared to occur over nonneuronal ganglion cells, and this was more evident when tissue sections were examined by phase contrast microscopy. Although these results supported the usual neuronal site of HSV-2 latency, latency in nonneuronal cells may be important in considering the pathobiology of HSV-2 infections.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850049      PMCID: PMC240642     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome.

Authors:  A M Deatly; J G Spivack; E Lavi; D R O'Boyle; N W Fraser
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Herpes simplex virus type 2 establishes latency in the mouse footpad.

Authors:  G B Clements; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1988-02       Impact factor: 3.891

3.  Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia.

Authors:  D H Gilden; Y Rozenman; R Murray; M Devlin; A Vafai
Journal:  Ann Neurol       Date:  1987-09       Impact factor: 10.422

4.  Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection.

Authors:  M L Cook; J G Stevens
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

5.  Recovery of herpes simplex virus from the corneas of experimentally infected rabbits.

Authors:  S D Cook; S K Batra; S M Brown
Journal:  J Gen Virol       Date:  1987-07       Impact factor: 3.891

6.  Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia.

Authors:  P R Krause; K D Croen; S E Straus; J M Ostrove
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses.

Authors:  K D Croen; J M Ostrove; L J Dragovic; S E Straus
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames.

Authors:  S L Wechsler; A B Nesburn; R Watson; S M Slanina; H Ghiasi
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 9.  Role of herpes simplex virus thymidine kinase expression in viral pathogenesis and latency.

Authors:  R B Tenser
Journal:  Intervirology       Date:  1991       Impact factor: 1.763

10.  RNA complementary to herpes simplex virus type 1 ICP0 gene demonstrated in neurons of human trigeminal ganglia.

Authors:  Y J Gordon; B Johnson; E Romanowski; T Araullo-Cruz
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  7 in total

1.  Localization of cis-acting sequence requirements in the promoter of the latency-associated transcript of herpes simplex virus type 1 required for cell-type-specific activity.

Authors:  A H Batchelor; P O'Hare
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 2.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 3.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

4.  Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus.

Authors:  M F Kramer; D M Coen
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

5.  The 2.2-kilobase latency-associated transcript of herpes simplex virus type 2 does not modulate viral replication, reactivation, or establishment of latency in transgenic mice.

Authors:  K Wang; L Pesnicak; E Guancial; P R Krause; S E Straus
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Cell type specific accumulation of the major latency-associated transcript (LAT) of herpes simplex virus type 2 in LAT transgenic mice.

Authors:  Kening Wang; Gowtham Mahalingam; Yumi Imai; Lesley Pesnicak; Todd P Margolis; Todd T Margolis; Stephen E Straus; Jeffrey I Cohen
Journal:  Virology       Date:  2009-02-06       Impact factor: 3.616

7.  Selective vulnerability of mouse CNS neurons to latent infection with a neuroattenuated herpes simplex virus-1.

Authors:  S Kesari; V M Lee; S M Brown; J Q Trojanowski; N W Fraser
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.